View in EDS HTML Full Text PDF Full Text

Resveratrol Attenuates High Glucose-Induced Osteoblast Dysfunction via AKT/GSK3β/FYN-Mediated NRF2 Activation.

Saved in:
Bibliographic Details
Title: Resveratrol Attenuates High Glucose-Induced Osteoblast Dysfunction via AKT/GSK3β/FYN-Mediated NRF2 Activation.
Authors: Xuan Y; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China., Wang J; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China., Zhang X; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China., Wang J; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China., Li J; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China., Liu Q; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China., Lu G; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China., Xiao M; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China., Gao T; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China., Guo Y; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China., Cao C; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China., Chen O; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China., Wang K; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China., Tang Y; Department of Orthopedic Surgery, The First Affiliated Hospital of Shandong First Medical University, Jinan, China., Gu J; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China.
Source: Frontiers in pharmacology [Front Pharmacol] 2022 May 23; Vol. 13, pp. 862618. Date of Electronic Publication: 2022 May 23 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35677434
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Resveratrol Attenuates High Glucose-Induced Osteoblast Dysfunction via AKT/GSK3β/FYN-Mediated NRF2 Activation.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Xuan+Y%22">Xuan Y</searchLink>; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China.<br /><searchLink fieldCode="AU" term="%22Wang+J%22">Wang J</searchLink>; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China.<br /><searchLink fieldCode="AU" term="%22Zhang+X%22">Zhang X</searchLink>; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China.<br /><searchLink fieldCode="AU" term="%22Wang+J%22">Wang J</searchLink>; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China.<br /><searchLink fieldCode="AU" term="%22Li+J%22">Li J</searchLink>; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China.<br /><searchLink fieldCode="AU" term="%22Liu+Q%22">Liu Q</searchLink>; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China.<br /><searchLink fieldCode="AU" term="%22Lu+G%22">Lu G</searchLink>; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China.<br /><searchLink fieldCode="AU" term="%22Xiao+M%22">Xiao M</searchLink>; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China.<br /><searchLink fieldCode="AU" term="%22Gao+T%22">Gao T</searchLink>; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China.<br /><searchLink fieldCode="AU" term="%22Guo+Y%22">Guo Y</searchLink>; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China.<br /><searchLink fieldCode="AU" term="%22Cao+C%22">Cao C</searchLink>; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China.<br /><searchLink fieldCode="AU" term="%22Chen+O%22">Chen O</searchLink>; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China.<br /><searchLink fieldCode="AU" term="%22Wang+K%22">Wang K</searchLink>; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China.<br /><searchLink fieldCode="AU" term="%22Tang+Y%22">Tang Y</searchLink>; Department of Orthopedic Surgery, The First Affiliated Hospital of Shandong First Medical University, Jinan, China.<br /><searchLink fieldCode="AU" term="%22Gu+J%22">Gu J</searchLink>; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2022 May 23; Vol. 13, pp. 862618. <i>Date of Electronic Publication: </i>2022 May 23 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35677434
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fphar.2022.862618
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 862618
    Titles:
      – TitleFull: Resveratrol Attenuates High Glucose-Induced Osteoblast Dysfunction via AKT/GSK3β/FYN-Mediated NRF2 Activation.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Xuan Y
      – PersonEntity:
          Name:
            NameFull: Wang J
      – PersonEntity:
          Name:
            NameFull: Zhang X
      – PersonEntity:
          Name:
            NameFull: Wang J
      – PersonEntity:
          Name:
            NameFull: Li J
      – PersonEntity:
          Name:
            NameFull: Liu Q
      – PersonEntity:
          Name:
            NameFull: Lu G
      – PersonEntity:
          Name:
            NameFull: Xiao M
      – PersonEntity:
          Name:
            NameFull: Gao T
      – PersonEntity:
          Name:
            NameFull: Guo Y
      – PersonEntity:
          Name:
            NameFull: Cao C
      – PersonEntity:
          Name:
            NameFull: Chen O
      – PersonEntity:
          Name:
            NameFull: Wang K
      – PersonEntity:
          Name:
            NameFull: Tang Y
      – PersonEntity:
          Name:
            NameFull: Gu J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 05
              Text: 2022 May 23
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 1663-9812
          Numbering:
            – Type: volume
              Value: 13
          Titles:
            – TitleFull: Frontiers in pharmacology
              Type: main
ResultId 1